We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

What happened in the stock market today

Woodford Equity Fund calls it a day, while Woodford Patient Capital (LON: WPCT) loses big.

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Trading in the major market indices has been subdued today, with the FTSE 100 down just a quarter of one percent as I write, and the FTSE 250 up half a percentage point. However, the pound reached a five-month high against the euro on comments from lead EU Brexit negotiator Michel Barnier that a deal is possible. 

Regardless, today is likely to be the deadline for any deal, as it would need to be ratified by EU leaders at Wednesday’s summit. If it does not agree to the deal, it will consider an extension. In the event that a Brexit deal is not reached, Saturday will then become the new deadline for Parliament to decide whether to ask for an extension to Article 50.

Should you buy Rolls Royce shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Woodford Equity Fund

The time is finally up for Neil Woodford’s Equity Income Fund. Today, the decision was made to not re-open the fund for trading, and instead to appoint an external asset manager to conduct an orderly sale of its holdings. 

The fund was suspended back in June, when mounting levels of redemptions caused a liquidity crisis, locking in investors in an attempt to allow Woodford to generate some much-needed cash. Woodford had a large number of illiquid assets on its books, which made it difficult to return capital to investors when they started losing confidence in his management. Ironically, it was the previous wave of redemptions that forced Woodford to sell many of his large-caps, thereby making illiquid assets a much larger proportion of his overall portfolio.

What does this mean for investors in the fund? Unfortunately, they will have to wait until at least January to get their money back. The liquidation process has to be drawn out to ensure that Woodford’s assets are sold at reasonable prices, which ultimately should ensure that investors will get as much of their capital back as possible. Still, this is hardly the news that they would have wanted to hear.

Unsurprisingly, Neil Woodford himself believes that his firing and the liquidation of his fund is a mistake, stating: “This was Link’s [the appointed corporate director’s] decision and one I cannot accept, nor believe is in the long-term interests of LF Woodford Equity Income Fund investors”.

Meanwhile, questions continue to percolate about the future of his other investment vehicle, Woodford Patient Capital (LSE: WPCT), shares of which are down almost 9% today. Although it is a separate entity to the Equity Income Fund, investors are now questioning its governance and management’s decision-making, fearing that the same problems could rear their ugly heads again. There is speculation that Neil Woodford could be replaced as head of Patient Capital, and that it may cease to exist altogether. 

Perhaps the lesson to be learned from this is that internal governance can be weak in funds headed by celebrity investment managers. As with stocks, it is often advisable to invest in relatively unknown entities. Or better yet, get a Stocks and Shares ISA and take control of your retirement savings. 

Stepan Lavrouk owns no shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Golden Retirees Heading to Beach
Investing Articles

4 steps to building a £38,456 retirement income with ISA shares

Investing £300 a month could deliver a life-changing cash stream in retirement with high-yield income shares. Royston Wild explains how.

Read more »

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How investing in a Cash ISA could cost you a comfortable retirement

Cash ISAs are celebrated for the brilliant tax benefits they provide. But could focusing on them cost savers the chance…

Read more »

Young black woman in a wheelchair working online from home
Investing Articles

How much could Barclays shares pay in dividends by 2028?

Barclays is one of the FTSE 100's most popular dividend shares. How much could they provide over the next three…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With a 6% yield and a P/E of just 7.4, is this share a screaming buy for a second income?

Mark Hartley looks at the second income potential of a popular UK dividend stock that still looks undervalued despite compelling…

Read more »

Investing Articles

Forget Nvidia! This ETF is booming inside my Stocks and Shares ISA

A thematic ETF inside this writer's ISA has more doubled the return of Nvidia stock so far in 2026. But…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

These cheap FTSE 250 shares could deliver a £1,550 ISA income in just 12 months!

Searching for the best low-cost dividend stocks to buy? Royston Wild reveals two FTSE 250 property shares with yields above…

Read more »

Landlady greets regular at real ale pub
Investing Articles

How much in dividends will these high-yield shares generate in 2026?

With 9.5% and 8.4% dividend yields, what makes these FTSE 100 and FTSE 250 high-yield heroes so special? Royston Wild…

Read more »

British pound data
Investing Articles

£5,000 invested in Nvidia shares when ChatGPT was released is now worth…

The rise of Nvidia shares was kickstarted by the advent of ChatGPT. Our author takes a look at how much…

Read more »